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Abstract
Ultrasound is among the most widely used non-invasive imaging modalities in biomedicine1, but 
plays a surprisingly small role in molecular imaging due to a lack of suitable molecular reporters 
on the nanoscale. Here we introduce a new class of reporters for ultrasound based on genetically 
encoded gas nanostructures from microorganisms, including bacteria and archaea. Gas vesicles are 
gas-filled protein-shelled compartments with typical widths of 45–250 nm and lengths of 100–600 
nm that exclude water and are permeable to gas2, 3. We show that gas vesicles produce stable 
ultrasound contrast that is readily detected in vitro and in vivo, that their genetically encoded 
physical properties enable multiple modes of imaging, and that contrast enhancement through 
aggregation permits their use as molecular biosensors.
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Contrast-enhanced ultrasound has been an active area of research and development for over 
40 years4, with conventional ultrasound contrast agents formulated as lipid- or protein-
stabilized gas microbubbles. The partial pressure gradient between a microbubble’s gas 
interior and surrounding media, which is inversely proportional to its radius, limits most 
microbubbles to sizes larger than one micron and leads to gas escape, bubble fragmentation 
and collapse after in vivo administration5, 6. Although microbubbles have been very 
successful in clinical imaging of the blood pool and related physiology7, and have recently 
been proposed as potential cell-internalized labels8, several factors limit their range of 
applications in molecular imaging. For example, microbubbles of micron size are typically 
limited to imaging targets within the vasculature. In addition, microbubbles typically have a 
short half-life compared to the in vivo dynamics of immune, stem and other cells5, 7, 9. 
Furthermore, none of the solid10, liquid11, hollow12 or phase-change13 contrast agents 
proposed as microbubble alternatives have so far become widely adopted due to limitations 
in echogenicity, stability or ease of synthesis. As a result, important studies in oncology, 
immunology, regenerative medicine and other biomedical areas remain dominated by 
nanoparticle reporters designed for optical, magnetic resonance and nuclear imaging14.
We hypothesized that nanoscale reporters with novel properties for molecular 
ultrasonography could be derived from natural biological structures. In particular, we 
considered gas vesicles (GVs), genetically encoded gas nanostructures formed by certain 
bacteria and archaea as a means to control buoyancy for optimal access to light and 
nutrients2, 3. GVs have cylindrical or biconical shapes, with maximal diameters of 45–250 
nm and typical lengths of 100–600 nm varying between genetic hosts 2, 3. These 
nanostructures interact with gases through a fundamentally different mechanism than 
microbubbles. Whereas microbubbles trap pre-loaded gas, GVs exclude water but permit gas 
from the surrounding media to freely diffuse in and out of their 1–10 attoliter interior 
through a 2 nm protein shell2 (Fig. 1a). As a result, no pressure gradient exists between the 
inside and outside of GVs, permitting them to be inherently stable despite their nanometer 
size. Although they were discovered over 100 years ago15 and have been well-characterized 
biophysically2, GVs have yet to be substantially exploited as a nanotechnology3. We 
hypothesized that GVs could serve as nanoscale molecular reporters for ultrasound imaging, 
and furthermore that their genetically encoded structural properties, such as collapse at 
specific hydrostatic pressures, could enable new imaging modes beyond those available with 
microbubbles.
To test this hypothesis, GVs from Anabaena flos-aquae (Ana) and Halobacterium NRC-1 
(Halo) (Fig. 1, b–c), representing two genetically distant sources3, were purified through 
tonic cell lysis and centrifugally assisted floatation and imaged in gel phantoms using a 
scanning single-element ultrasound imaging system operating at 4.8 MHz, 8.6 MHz and 17 
MHz (for sample preparation and imaging details, see Methods). GVs from both species 
produced robust contrast relative to buffer controls at optical densities (OD) ranging from 
0.25 to 2.0 (Fig. 1d–g), corresponding to nanostructure concentrations of 150 pM to 1.2 nM 
(Ana) or 5 pM to 40 pM (Halo), and gas volume fractions of approximately 0.01% to 0.1%. 
GV echogenicity in this configuration was detectable for over one week (Supplementary 
Fig. 1). Contrast was strongest at the highest frequency, with OD 2.0 Ana GVs producing 
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27.0 ± 4.1 greater scattering than buffer controls (Fig. 1f). The balance of scattering and 
attenuation differed between Ana and Halo GVs. Whereas Ana GVs produced backscatter 
fairly uniformly along the axial dimension (from top to bottom in Fig. 1d), Halo GVs at 
higher concentrations produced acoustic attenuation, manifesting as reduced signal beneath 
the gas vesicles in the gel phantom (Fig. 1e, Supplementary Fig. 2).
GVs can be collapsed by rapidly increasing the hydrostatic pressure past a species-specific 
critical point ranging from 40 kPa to over 700 kPa 2, 16 (Fig. 1b–c). GVs that were 
hydrostatically collapsed prior to loading into the phantom failed to show ultrasound 
contrast, confirming the echogenic role of their gas compartments (Fig. 1, d–e).
Non-linear imaging modes relying on harmonic signals have been used to improve the 
contrast specificity of microbubble-enhanced ultrasound17. In particular, harmonic 
backscatter is thought to arise from oscillations in microbubble radius18 in response to 
incident pressure waves. We tested whether harmonics could also be detected from GVs. 
Transmitting at 6 MHz, we observed substantial second and third harmonic signals in Halo 
GVs at 12 MHz and 18 MHz compared to polystyrene microspheres, a linear scattering 
reference material (Fig. 2a). Ana GVs did not produce harmonic signals at 6 MHz 
(Supplementary Fig. 3). Images formed by processing Halo GV signals through band-pass 
filters centered at the second and third harmonics showed 3.7-fold and 4.6-fold greater 
contrast enhancement in GV-containing wells relative to the linear scatterer than did images 
processed at the transmit frequency (Fig. 2b, c). To further explore GV-specific contrast 
enhancement, we took advantage of pressure-induced GV collapse by testing its application 
in situ at ultrasound frequencies. Halo and Ana GVs were imaged before and after a 
disruptive scan at 8.6 MHz in which the transducer output was set to produce a peak 
pressure of 650 kPa – above the critical collapse level of both species of GVs (70–150 kPa 
for Halo and 440–605 kPa for Ana)16 (Fig. 2d). The GV signal was thereby mostly 
eliminated, enabling the generation of subtraction images in which the signal from Halo and 
Ana GV wells relative to polystyrene was boosted by factors of 10 and 22, respectively. 
(Fig. 2d, e). Such subtraction images can be used to increase the specificity of contrast 
information relative to background scattering19.
The fact that GVs from different species have distinct critical collapse pressures16 raised the 
further prospect of distinguishing multiple populations of GVs in the same sample through 
“serial collapse” imaging. In this paradigm, contrast originating from GVs with a low 
collapse pressure is identified by its disappearance upon the application of pressure pulses 
with amplitudes above their critical point but below that of other GVs. The remaining 
contrast is attributable to GV species with higher collapse pressures. To test this paradigm 
with our two species of GVs, we prepared imaging phantoms with wells containing Halo 
GVs, Ana GVs or a combination of both (Fig. 2f). In an initial image, both populations of 
GVs produce contrast (Fig 2f, top), but after low-pressure collapse at 300 kPa, contrast in 
the Halo GV well is eliminated and contrast in the mixed well is reduced (Fig 2f, middle). 
After high-pressure collapse at 650 kPa, contrast in the Ana GV well and the mixed well is 
also eliminated, leaving only background (Fig 2f, bottom). Halo GV contrast can now be 
inferred by subtracting the second image from the first image (Fig 2g, top) and Ana GV 
contrast can be calculated by subtracting the third image from the second image (Fig 2g, 
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bottom). An overlay correctly shows the mixed well as containing both types of GVs (Fig. 
2h).
Because GVs are smaller than the wavelengths typically used in ultrasound, we further 
hypothesized that assemblies of GV nanoparticles would produce enhanced scattering 
compared to un-aggregated solutions, as previously shown with perfluorocarbon droplets11, 
potentially enabling GVs to serve as biomolecular sensors analogous to aggregation-
dependent nanoparticle reporters for magnetic resonance imaging (MRI)20. To test this 
possibility, we functionalized the surface of Ana GVs with biotin and exposed them to 
various quantities of free streptavidin. In the absence of streptavidin, or at streptavidin 
concentrations sufficient to saturate surface biotins, GVs are expected to remain 
unaggregated; however, at intermediate concentrations, streptavidin is expected to mediate 
GV clustering (Fig. 3a). The formation of aggregates (~1 µm) in response to streptavidin 
was confirmed by TEM (Fig. 3d), and at higher magnification it was also possible to discern 
individual streptavidin molecules on the surface of GVs at the expected relative densities 
(arrows in Fig. 3d). When nanoparticle assemblies were imaged in ultrasound, the 
intermediate streptavidin concentration was detected by a two-fold increase in contrast (Fig. 
3b, c). Ana GVs were chosen for functionalization because their greater resistance to 
collapse (compared to Halo GVs) allows easier handling during repeated purifications.
Next, to test the feasibility of using GVs expressed inside cells as intracellular reporters or 
genetic labels, we imaged intact Ana cells and compared the resulting contrast to GVs that 
were released from the same quantity of cells through hypertonic lysis (Fig. 3e–g). The 
intact cells exhibited a 12-fold stronger signal, indicating that intracellular GVs have the 
potential to serve as genetically encoded reporters or dynamic indicators of cellular integrity. 
The quantity of GVs recovered after lysis (815 ± 124 µL gas volume per g of dry cell pellet, 
N=4) was greater than previously measured intracellular GV contents (~350–500 µL/g)21, 22, 
suggesting that the observed difference in contrast between intact and lysed cells is unlikely 
to arise from GV destruction during lysis.
Finally, to demonstrate that GVs are capable of producing ultrasound contrast in vivo, we 
performed subcutaneous and intravenous injections of Halo GVs into live anaesthetized 
mice, choosing Halo GVs for their robust non-linear signals (Fig. 2a). We first injected the 
GVs or a buffer control subcutaneously in the lower abdomen of anesthetized CD-1 mice, 
and acquired second-harmonic images (transmitting at 6 MHz) using our single-element 
apparatus. We observed robust enhancement on the GV side (Fig. 4a, b, d), but not on the 
control side. To confirm that GVs were the source of the observed contrast, we applied 
ultrasonic pulses at a supra-collapse pressure (650 kPa), resulting in contrast disappearance 
(Fig. 4c, d). Regions of interest containing GVs exhibited 60 ± 14% stronger backscattered 
signals than buffer-injected controls (p = 0.008); this difference disappeared after collapse (p 
= 0.23). Images from five animals are shown in Supplementary Fig. S4. In addition, we used 
a commercial high frequency small animal ultrasound scanner operating at 18 MHz to image 
the dynamics of Halo GVs (50 µL, OD 6.0) injected into the tail vein of severe-combined 
immunodeficient (SCID) nude mice. Five seconds after the start of the injection (at a rate of 
0.6 mL/min), robust scattering was observed from the inferior vena cava in non-linear 
contrast images (Fig. 4 e, h, i and Supplementary Movie S1). Then, as expected for 
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unfunctionalized nanostructures, GV contrast accumulated in the liver, reaching a steady 
state after approximately 50 seconds (Fig. 4 f, h, j and Supplementary Movie S1). 
Application of a high-power burst from the transducer completely eliminated the 
accumulated contrast (Fig. 4 g, h, i, j and Supplementary Movie S1). Under these conditions, 
GVs were detectable in vivo when injected at concentrations as low as OD 1.5 in the inferior 
vena cava (Fig. 4k), and OD 3.0 in the liver (Fig. 4l); contrast increased with dosing above 
these levels.
No acute toxicity was observed in the intravenously injected mice. The animals’ heart rate 
and breathing remained normal during and after imaging (Supplementary Fig. S5), and no 
significant decrease in five veterinary health measures (activity, weight, food intake, posture 
and hydration) was observed immediately or 24 and 48 hours after GV administration 
(Supplementary Table S2). GVs taken up by the liver appeared to be degraded within 60 
minutes of uptake (Supplementary Fig. S6) consistent with other protein nanostructures 
cleared by this organ, e.g. bacteriophage23. However, when GVs were injected 
subcutaneously, occupying a tissue that lacks rapid nanoparticle clearance and protein 
degradation, they produced stable contrast for at least two hours (Supplementary Fig. S7).
Our findings establish GVs as a promising new class of molecular reporters for 
ultrasonography. Their ability to produce stable contrast at sub-nanomolar reporter 
concentrations may enable future applications of ultrasound in imaging studies that, to date, 
have been dominated by nanoparticle reporters for other modalities such as MRI and 
fluorescence14. These concentrations represent gas contents (< 1 µL gas / mL solution) 
similar to or smaller than those of typical formulations of microbubbles, which contain 
approximately 103 times more gas per particle19. Furthermore, several of the demonstrated 
acoustic properties, including response at high frequencies (up to the measured 18 MHz), 
ability to produce harmonic signals (in Halo GVs) and controlled acoustic collapsibility in 
situ, are especially advantageous for high-resolution contrast-enhanced imaging24. Future 
work is needed to determine how these properties are influenced by the specific size, shape, 
elasticity, gas diffusivity and collapse-resistance of these nanostructures. Some insights may 
be gained by refining existing microbubble theories, which predict peak responses at 
frequencies > 18 MHz for contrast agents with submicron size and relatively high 
stiffness18, 25–27. In addition, differences in the physical properties of GVs obtained from 
distinct species, such as sharply tuned collapse pressures and harmonic scattering, may 
enable new detection schemes, as shown here with serial collapse imaging of GVs from Ana 
and Halo.
Application-specific reporters can be generated by functionalizing the surface of GVs 
through bioconjugation, as shown here with clustering-based analyte (streptavidin) detection 
by biotinylated Ana GVs. The nanometer dimensions of these structures may enable the 
labeling of targets outside the bloodstream, for example tumours with increased vascular 
permeability28, to be explored in future studies. As with other nanoscale imaging agents, 
PEGylation or other surface treatments may be necessary to increase circulation time, reduce 
clearance by organs such as the liver and decrease immunogenicity29. Future work is also 
needed to demonstrate the safety of GVs for potential clinical and pre-clinical applications, 
including ones that may require repeated administration.
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Intriguingly, the intracellular detectability of GVs suggests that they could in the future be 
developed as reporter genes for bacterial or mammalian cell tracking, potentially enabling 
longer-term monitoring than recently demonstrated with microbubbles8. Indeed, gene 
clusters encoding GVs have already been heterologously expressed in Escherichia coli 30. 
Furthermore, genetic sequence control over the size, shape and collapse pressures of GVs in 
their native hosts3 could assist with the optimization of GV properties for future use as 
either injectable or encoded reporters.
Finally, we note that GVs’ well-defined molecular structures, anisotropic shapes, hollow 
interiors, gas permeability, optical scattering, buoyancy, chemical reactivity, controlled 
collapse and genetic encoding could conceivably make them useful in various other 
nanotechnology applications.
Methods
Additional details are provided in the Supplementary Information.
Gas vesicle preparation
Anabaena flos-aquae (Ana) was cultured in Gorham’s media at room temperature under 
office fluorescent lighting. Halobacteria NRC-1 (Halo) was cultured with shaking at 37°C 
in ATCC medium 2185, under ambient light. GVs were isolated from Ana and Halo using 
hypertonic and hypotonic lysis, respectively, and purified by repeated centrifugally-assisted 
flotation (Supplementary Fig. S8). Pre-collapsed GVs were prepared through the application 
of hydrostatic pressure in a capped syringe.
The concentration of GVs was estimated based on pressure-sensitive optical density at 500 
nm (OD500,PS)2. The relationship between OD500,PS and protein concentration was 
determined empirically using a total protein assay. Literature-based estimates of molecular 
weight31–33 were used to calculate molar concentrations. Gas volume fractions were 
estimated using gas volumes of 8.4 µL/mg and 12.3 µL/mg for Ana and Halo GVs, 
respectively32, 33.
For experiments comparing intact and lysed cells, Ana cultures (cell OD600nm ~ 2) were 
mixed 50:50 with either water or 50% sucrose for 60 minutes before imaging. GVs release 
was measured using OD500,PS and compared to dry cell pellet weight.
Bio-functionalization and aggregation
Ana GVs were biotinylated using Sulfo-NHS-LC-Biotin and purified by 3X repeated 
floatation. For aggregation experiments, biotinylated GVs were mixed with streptavidin at 
indicated molar ratios for approximately 30 minutes before imaging.
In vitro ultrasound imaging
Imaging phantoms were prepared from 1% agarose in water. 2X concentrated GV samples 
were mixed 1:1 with melted 1% agarose, and 100uL of the mixture was quickly loaded into 
phantom wells. The same procedure was used to load polystyrene microspheres (0.83% final 
w/v, 4.78 µm). Imaging was performed using a home-built imaging setup. A 5 MHz, 10 
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MHz or 20 MHz single element transducer (6.3, 6.3 and 3.2 mm active areas, respectively; 
25.4 mm focal distance) was mounted on a computer-controlled 2D translating stage, 
immersed in water approximately 20 mm above the sample. A programmable pulse 
generator and radio frequency amplifier drove transducers at specified frequencies with 
sinusoidal pulse trains of approximately 1 µs. The pre-amplifier function of a pulse-receiver 
with high-pass and low-pass filtering at 5 MHz and 75 MHz, connected to an oscilloscope, 
was used to collect ultrasound signals and record them using MATLAB (Mathworks, 
Natick, MA). In situ GV collapse was obtained by repeated pulsing at indicated pressures at 
8 or 8.6MHz.
Image analysis
MATLAB was used to process raw time-domain data into two-dimensional (B-mode) 
images. If multiple neighboring lines perpendicular to the B-mode image were acquired, 
they were averaged. Regions of interest were defined manually in the axial dimension and 
automatically in the lateral dimension. Processing and scaling parameters are listed in 
Supplementary Table 1. Colour maps used in the images are shown in Supplementary Figure 
S9. Power spectra represent squared absolute values of fast Fourier transforms of raw time-
domain signals.
In vivo imaging
For imaging of subcutaneously injected GVs (Fig. 4a–d) female CD-1 mice under isoflurane 
anesthesia were depilated above the lower abdomen and injected subcutaneously with 150uL 
Halo GVs (OD 6) on one side and 150uL PBS on the other side of the abdomen. An 
ultrasonic transducer was coupled through a column of ultrasound gel above the injected 
region and scanned or used to apply destructive pulses as described above.
Intravenously injected GVs were imaged in SCID nude mice using the VisualSonics Vevo 
2100 high frequency ultrasound scanner operating in non-linear contrast mode, with the 
MS250 transducer set to 18 MHz and 2% power. The mice were maintained under 
isoflurane anesthesia on a heated imaging platform. Breathing and heart rate were monitored 
by built-in sensors. During infusion experiments, images were acquired continuously at a 
frame rate of 15frames/sec for approximately 100 seconds. 50 µL of Halo GVs in PBS were 
infused approximately 10 seconds after the start of the experiment at a flow rate of 0.6 mL/
min. After 65 seconds, a burst pulse was applied to collapse the GVs. ROIs were analyzed 
using Vevo Lab software. Smoothed infusion time course curves were generated using 
locally weighed scatterplot smoothing. AUC values were obtained from raw data normalized 
to the pre-infusion baseline. Halo GVs remaining in the liver following intravenous injection 
were imaged as described above, with the additional collection of images during 30-second 
windows at 15, 30, 45, 60 and/or 75 minutes after injection. In subcutaneous injection 
experiments, 100 µL OD 6.0 Halo GVs were injected subcutaneously on the right side of the 
abdomen and 100 µL PBS was injected contralaterally.
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Veterinary evaluation
Animals were evaluated by a veterinarian on a 15-point scale comprising three points each 
for activity, weight, food intake, posture and hydration. The veterinarian was blinded to the 
injection group.
TEM
TEM images were obtained on a Philips/FEI (Hillsboro, OR) Tecnai 12 microscope 
operating at 120kV. GV samples (OD 0.1) were deposited on a carbon-coated formvar grid 
and stained with 2% uranyl acetate.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Gas vesicles produce ultrasound contrast
a, Diagram of a gas vesicle: a hollow gas nanocompartment (solid shading) surrounded by a 
gas-permeable protein shell (ribbed shading). b, TEM images of intact (left) and 
hydrostatically collapsed (right) Ana GVs. c, TEM images of intact (left) and collapsed 
(right) Halo GVs. All scale bars 200 nm. d, Ultrasound images of a gel phantom containing 
PBS buffer, Ana GVs at optical densities ranging from OD 0.25 to 2 (concentrations of 150 
pM to 1.2 nM) or collapsed Ana GVs (OD 2.0). Images were acquired at multiple 
frequencies, as indicated. e, Ultrasound images of a gel phantom containing PBS buffer, 
Halo GVs at optical densities ranging from OD 0.25 to 2 (concentrations of 5 to 40 pM) or 
collapsed Halo GVs (OD 2.0). Conversion between OD, molar concentration and gas 
volume fraction is described in the Methods. f, Total backscattered signal relative to PBS at 
each frequency and Ana GV concentration (N=4 per sample). g, Total backscattered signal 
relative to PBS at each frequency and Halo GV concentration (N=4 per sample). Detailed 
image acquisition and analysis parameters are provided in Supplementary Table S1; colour 
maps for ultrasound images in Supplementary Fig. S9. The size of each field of view is 
indicated in the lower right corner of the image. All error bars represent ± SEM.
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Figure 2. Non-linear imaging and genetic diversity enable enhanced contrast specificity and 
selective disruption imaging
a, Power spectrum of signal backscattered from Halo GVs (black) and 4.78 µm polystyrene 
(PS) microspheres (red) in response to 6 MHz transmitted pulses (peak amplitude 98 kPa, 
labeled “Transmit” in the figure), Each point on the spectrum represents an average of 48 
points from 3 samples (16 points per sample). The orange, green and blue highlights 
correspond to frequency bands used to generate the images in (b). b, Ultrasound images of 
Halo GVs and PS microspheres acquired with 6 MHz transmission and band-pass filtered 
around 6, 12 and 18 MHz. c, Ratio of total backscattered signal from Halo GVs and PS 
microspheres after filtering at the indicated frequencies (N=4). d, Ultrasound images of 
Halo GVs, Ana GVs and PS microspheres at 8.6MHz acquired before (Pre) and after (Post) 
destructive collapse with 650 kPa insonation, and the difference (Diff.) between these 
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images. e, Ratio of total backscattered signal from GVs and PS microspheres in pre-collapse 
and difference images (N=4). The concentrations used in (a)-(e) were OD 0.5 Halo GVs, 
OD 2.0 Ana GVs and 0.83% w/v polystyrene. f, Ultrasound images of a phantom containing 
wells with PBS, a mixture of Ana and Halo GVs, or each type of GVs on its own (all GVs at 
OD 1.0 in PBS), acquired at 8.6 MHz. Top: before collapse. Middle: after collapse at 300 
kPa. Bottom: after collapse at 650 kPA. g. Top: difference between the top and middle 
images in (f), Bottom: difference between the middle and bottom images in (f). h. Overlay 
of the two images in (g). Detailed image acquisition and analysis parameters are provided in 
Supplementary Table S1; colour maps for ultrasound images in Supplementary Fig. S9. The 
size of each field of view is indicated in the lower right corner of the image. All error bars 
represent ± SEM.
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Figure 3. Gas vesicles act as biomolecular sensors and report cellular integrity
a, Illustration of predicted aggregation interactions between surface-biotinylated GVs 
(hexagons with gray arrows) and streptavidin (SA) at different SA:GV ratios. b, 17 MHz 
image of OD 1.0 biotinylated Ana GVs mixed with the indicated ratio of SA. c, Integrated 
signal intensity relative to phantom background corresponding to the SA:GV conditions in 
(b) (N=4 per condition). d, TEM images of Ana GVs incubated with SA at the indicated 
molar ratios on the top right hand corner of each panel. At the higher magnification (right), 
arrows indicate apparent SA molecules on the GV surface. Scale bars 2 µm (left) and 40 nm 
(right). e, Illustration of GVs (black hexagons) confined inside intact cells (orange) or 
released following lysis. f, Ultrasound image (17 MHz pulses) of Ana cells treated with 
water (intact) or with 25% sucrose (lysed). g, Integrated signal intensity relative to phantom 
background for intact and lysed cells (N=4 per condition). Detailed image acquisition and 
analysis parameters are provided in Supplementary Table S1; colour bars for ultrasound 
images in Supplementary Fig. S9. The size of each field of view is indicated in the lower 
right corner of the image. All error bars represent ± SEM.
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Figure 4. Gas vesicles produce ultrasound contrast in vivo
a, Overlay of second harmonic image (6 MHz pulses) in green on a grayscale broadband 
anatomical image of mouse lower abdomen injected subcutaneously with 150 µL OD 6.0 
Halo GVs on the right side and 150uL PBS on the left side. b–c, Second harmonic 
ultrasound image before (b) and after (c) GV collapse with destructive insonation (650 kPa). 
Dashed outlines show regions of interest (ROI) used to quantify signals. d. Total back-
scatted second harmonic signal from ROIs covering GV-injected (orange) and PBS-injected 
(blue) tissues, before and after collapse (N=5). e–g. Non-linear contrast images acquired 
using a high-frequency ultrasound scanner system (operating at 18 MHz and 2% power) of 
SCID nude mice infused intravenously with 50 µL OD 6.0 Halo GVs. The images show 
contrast at 4.5 seconds (e) and 64 seconds (f) after the start of infusion, or after the 
application of a burst pulse (g). The locations of the inferior vena cava (IVC) and liver are 
indicated with labels. h. Time course of the smoothed average non-linear signal in the IVC 
(blue) and liver (orange) during infusion. i. Mean average signal intensity in the IVC before 
(pre) during (peak) and after (steady) infusion, and after the burst pulse (post) (N=5). j. 
Mean average signal intensity in the liver before (pre) and after (steady) infusion, and after 
the burst pulse (post) (N=5). k–l. Dose-response relationship of 50 µL Halo GVs infused at 
OD 0 – 6.0 determined from the area under the curve (AUC) of average contrast in the IVC 
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(k) and liver (l) (N=5). Detailed image acquisition and analysis parameters are provided in 
Supplementary Table S1; colour maps for ultrasound images in Supplementary Fig. S9. The 
size of each field of view is indicated in the lower right corner of the image. All error bars 
represent ± SEM.
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